Navigation Links
Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
Date:11/8/2012

NEW YORK, Nov. 8, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of DUSA Pharmaceuticals, Inc. ("DUSA" or the "Company") (NASDAQ: DUSA) concerning the proposed acquisition of the Company by Sun Pharmaceutical Industries Ltd. ("Sun Pharmaceuticals") in a transaction valued at approximately $230 million. 

(Logo:  http://photos.prnewswire.com/prnh/20120215/MM54604LOGO )

On November 8, 2012, it was announced that DUSA and Sun Pharmaceuticals have entered into a definitive agreement pursuant to which Sun Pharmaceuticals will acquire DUSA.  Under the terms of the transaction, DUSA shareholders will receive $8.00 in cash per share held.  At least one analyst has set a target price for DUSA stock of $9.50 per share.

Our investigation concerns whether the DUSA board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company shareholders. 

If you own DUSA shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Benjamin Sachs-Michaels, Esq.

Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising © 2012 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.


'/>"/>
SOURCE Harwood Feffer LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
2. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
3. ActiveCare Announces Record Revenue For Quarter Ending June 30, 2012
4. Echo Therapeutics Announces Third Quarter 2012 Financial Results
5. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
6. Winner Medical Announces Mailing of Definitive Proxy Materials for Special Meeting of Shareholders
7. Genoa Pharmaceuticals announces $1.2M Financing
8. Genomic Health Announces Third Quarter 2012 Financial Results and Business Progress
9. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
10. Life Technologies Announces Next-Gen Digital PCR Instrument Designed for Widespread Adoption
11. Blue Belt Technologies Announces First United Kingdom-Based NavioPFS Unicondylar Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)...  Perrigo Company plc (NYSE, TASE: PRGO) today announced it ... Administration for hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), ... bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg ... cough in adults and children 6 years of age and ... were approximately $16 million.   ...
(Date:2/17/2017)... , Feb 17, 2017 Research and Markets has ... Report" report to their offering. ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , Latin America , ... period 2015 through 2022. Also, a six-year historic analysis is provided for ...
(Date:2/17/2017)... 2017  In partnership with CitiHope , ... , The Jack Brewer Foundation (JBF Worldwide) ... dollars, worth of medicine to Innovating Health International ... a non-profit dedicated to treating chronic diseases and addressing women,s ... Haiti and providing these medicines ...
Breaking Medicine Technology:
(Date:2/17/2017)... TN (PRWEB) , ... February 17, 2017 , ... ... mobility has not kept pace. Enovate Medical has introduced an innovative workstation designed ... years of supporting nurses, the Encore Mobile EHR Workstation offers a lightweight, highly ...
(Date:2/17/2017)... Rancho Palos Verdes, CA (PRWEB) , ... February ... ... well-being, and emotional flow is Dr. Carol Francis' goals for each ... Federation Retreat Conference, Dr. Carol Francis will demonstrate five different brainwave tools which ...
(Date:2/17/2017)... ... February 17, 2017 , ... MAP ... today that Karen Pilley has been promoted to Chief Executive Officer. , ... healthcare paradigm – a shift that demands the transition from pay-for-service to pay-for-performance ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists ... from February 21 - 23 in Beaver Creek, CO. It was announced today by ... second year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs ...
(Date:2/16/2017)... (PRWEB) , ... February 17, 2017 , ... Teaching nursing ... (ACE) program, now in development. ACE.P (pediatrics) is being created with the support of ... Care of Vulnerable Populations , ACE.P will address what has been identified as a ...
Breaking Medicine News(10 mins):